Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)

被引:0
作者
Andrew F Shorr
Jonathan M Janes
Antonio Artigas
Jyrki Tenhunen
Duncan LA Wyncoll
Emmanuelle Mercier
Bruno Francois
Jean-Louis Vincent
Burkhard Vangerow
Darell Heiselman
Amy G Leishman
Yajun E Zhu
Konrad Reinhart
机构
[1] Washington Hospital Center,Lilly Research Laboratories, Eli Lilly and Company
[2] Lilly Corporate Centre,Critical Care Center, Sabadell Hospital, CIBER Enfermedades Respiratorias
[3] Autonomous University of Barcelona,Critical Care Medicine Research Group in Department of Intensive Care Medicine
[4] Tampere University Hospital,Adult Intensive Care Unit
[5] Guy's and St Thomas' NHS Foundation Trust,Service de Réanimation Polyvalente
[6] Hopital Bretonneau-CHRU, CRICS group
[7] CHRU Dupuytren,Service de Réanimation Polyvalente
[8] Erasme University Hospital, CIC
[9] Université Libre de Bruxelles,P 0801 Inserm
[10] Friedrich-Schiller University, CRICS group
来源
Critical Care | / 14卷
关键词
Severe Sepsis; Alternative Therapy; Drotrecogin Alfa; Data Monitoring Committee; Interactive Voice Response System;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 146 条
[1]  
Levy MM(2010)The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis Crit Care Med 38 367-374
[2]  
Dellinger RP(1991)Protein S and C alterations in acutely ill patients Am J Hematol 36 14-19
[3]  
Townsend SR(2001)Efficacy and safety of recombinant activated protein C for severe sepsis N Engl J Med 344 699-709
[4]  
Linde-Zwirble WT(2001)Low levels of protein C are associated with poor outcome in severe sepsis Chest 120 915-922
[5]  
Marshall JC(2004)Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism Crit Care 8 R82-R90
[6]  
Bion J(1992)Septic shock, multiple organ failure, and disseminated intravascular coagulation: Compared patterns of antithrombin III, protein C and protein S deficiencies Chest 101 816-823
[7]  
Schorr C(1993)Time course of hemostatic abnormalities in sepsis and its relation to outcome Chest 103 1536-1542
[8]  
Artigas A(2000)Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications Crit Care Med 28 2209-2216
[9]  
Ramsay G(2008)Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated) Crit Care 12 R45-S228
[10]  
Beale R(2004)Severe protein C deficiency predicts early death in severe sepsis Crit Care Med 32 S223-23